Company Filing History:
1 out of 822 
1 out of 167 
Years Active: 2022
Title: **Esther Birtalan: Innovator in Pharmaceutical Solid Dispersions**
Introduction
Esther Birtalan is a distinguished inventor based in Karlsruhe, Germany, known for her significant contribution to the field of pharmaceuticals. With a focus on innovative drug formulations, she holds a patent that addresses critical healthcare challenges, particularly in the treatment of diseases associated with Bcl-2 family proteins.
Latest Patents
Esther Birtalan's notable patent is titled “Melt-extruded solid dispersions containing an apoptosis-inducing agent.” This inventive approach involves a solid dispersion that features a pro-apoptotic solid dispersion containing a compound designated as Formula I. Notably, this compound is combined with a pharmaceutically acceptable water-soluble polymeric carrier and a surfactant. The process outlined in the patent emphasizes the preparation of this solid dispersion through a series of controlled thermal processes, ultimately rendering it suitable for oral administration. This innovative method holds promise for treating diseases characterized by the overexpression of anti-apoptotic Bcl-2 family proteins, including various types of cancer and autoimmune diseases.
Career Highlights
Throughout her career, Esther has demonstrated her expertise in the pharmaceutical industry, specifically through her work with prominent companies such as AbbVie Inc. and AbbVie Deutschland GmbH & Co. KG. Her experiences at these organizations have played a pivotal role in shaping her innovative approaches to drug formulation and delivery.
Collaborations
In her journey as an inventor, Esther has collaborated with notable colleagues, including Peter Hoelig and David J. Lindley. These partnerships have fostered a dynamic environment for innovation and scientific development, enhancing the quality and impact of her research contributions.
Conclusion
Esther Birtalan’s contributions to the field of pharmaceutical sciences through her patent on solid dispersions mark a significant step forward in addressing complex health issues. Her career and collaborations underscore her commitment to innovation in the healthcare sector, making her a notable figure in the realm of pharmaceutical inventions.